Plant ID: NPO11411
Plant Latin Name: Gossypium herbaceum
Taxonomy Genus: Gossypium
Taxonomy Family: Malvaceae
NCBI TaxonomyDB:
34274
Plant-of-the-World-Online:
n.a.
India; China
TSHR; | |
GAA; | |
BCL2; BCL2L1; | |
ESR1; | |
LDHB; ALOX12; LDHA; AKR1B1; HSD17B10; ALOX15; ALDH1A1; POLB; | |
KDM4E; | |
HIF1A; TP53; | |
SLCO1B3; SLCO1B1; | |
MPG; LMNA; MCL1; THPO; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Enzyme_unclassified | LDHB | L-lactate dehydrogenase B chain | P07195 | CHEMBL4940 |
Enzyme_unclassified | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Enzyme_unclassified | LDHA | L-lactate dehydrogenase A chain | P00338 | CHEMBL4835 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
Miscellaneous ion channel | BCL2 | Apoptosis regulator Bcl-2 | P10415 | CHEMBL4860 |
Miscellaneous ion channel | BCL2L1 | Apoptosis regulator Bcl-X | Q07817 | CHEMBL4625 |
Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | MPG | DNA-3-methyladenine glycosylase | P29372 | CHEMBL3396943 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | CHEMBL4361 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 2.953E-09 | 6.429E-05 | AKR1B1, ALDH1A1, ALOX12, ALOX15, CYP2A6, CYP2C19, GAA, HSD17B10, KDM4E, LDHA, LDHB |
BP | GO:0009987; cellular process | GO:0008630; intrinsic apoptotic signaling pathway in response to DNA damage | 1.879E-08 | 9.871E-05 | BCL2, BCL2L1, MCL1, POLB, TP53 |
MF | GO:0005488; binding | GO:0051434; BH3 domain binding | 1.683E-08 | 9.871E-05 | BCL2, BCL2L1, MCL1 |
BP | GO:0008152; metabolic process | GO:0006089; lactate metabolic process | 2.763E-07 | 7.520E-04 | HIF1A, LDHA, LDHB |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 5.560E-07 | 1.211E-03 | ALOX12, ALOX15, CYP2A6, CYP2C19 |
BP | GO:0050896; response to stimulus | GO:0010332; response to gamma radiation | 5.560E-07 | 1.211E-03 | BCL2, BCL2L1, POLB, TP53 |
BP | GO:0009987; cellular process | GO:2001244; positive regulation of intrinsic apoptotic signaling pathway | 6.447E-07 | 1.276E-03 | BCL2, BCL2L1, MCL1, TP53 |
BP | GO:0008152; metabolic process | GO:2001303; lipoxin A4 biosynthetic process | 1.480E-06 | 1.696E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0047977; hepoxilin-epoxide hydrolase activity | 1.480E-06 | 1.696E-03 | ALOX12, ALOX15 |
BP | GO:0032502; developmental process | GO:0048856; anatomical structure development | 4.579E-06 | 3.835E-03 | AKR1B1, ALOX15, BCL2, BCL2L1, ESR1, GAA, HIF1A, LDHA, LMNA, MCL1, POLB, THPO, TP53, TSHR |
BP | GO:0009987; cellular process | GO:2001243; negative regulation of intrinsic apoptotic signaling pathway | 5.410E-06 | 3.835E-03 | BCL2, BCL2L1, HIF1A, MCL1 |
BP | GO:0009987; cellular process | GO:0006284; base-excision repair | 6.693E-06 | 3.835E-03 | MPG, POLB, TP53 |
MF | GO:0003824; catalytic activity | GO:0004052; arachidonate 12-lipoxygenase activity | 4.435E-06 | 3.835E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0051120; hepoxilin A3 synthase activity | 4.435E-06 | 3.835E-03 | ALOX12, ALOX15 |
BP | GO:0008283; cell proliferation | GO:0008284; positive regulation of cell proliferation | 7.304E-06 | 3.838E-03 | AKR1B1, ALOX12, BCL2, BCL2L1, ESR1, HIF1A, THPO, TSHR |
BP | GO:0050896; response to stimulus | GO:0009636; response to toxic substance | 7.668E-06 | 3.838E-03 | AKR1B1, BCL2, BCL2L1, LDHA, POLB, TP53 |
BP | GO:0009987; cellular process | GO:0071456; cellular response to hypoxia | 7.756E-06 | 3.838E-03 | BCL2, HIF1A, LMNA, TP53 |
BP | GO:0009987; cellular process | GO:2001240; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 9.833E-06 | 4.556E-03 | BCL2, BCL2L1, MCL1 |
BP | GO:0008152; metabolic process | GO:0051122; hepoxilin biosynthetic process | 1.476E-05 | 5.448E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0004459; L-lactate dehydrogenase activity | 1.476E-05 | 5.448E-03 | LDHA, LDHB |
BP | GO:0050896; response to stimulus | GO:0010035; response to inorganic substance | 1.691E-05 | 5.911E-03 | AKR1B1, ALOX15, BCL2, HIF1A, LDHA, TP53 |
BP | GO:0050896; response to stimulus | GO:0034097; response to cytokine | 2.050E-05 | 6.663E-03 | ALOX15, BCL2, BCL2L1, HIF1A, MCL1, TP53 |
BP | GO:0065007; biological regulation | GO:0042592; homeostatic process | 2.103E-05 | 6.734E-03 | AKR1B1, ALOX12, BCL2, ESR1, GAA, HIF1A, MCL1, POLB, TP53 |
CC | GO:0032991; macromolecular complex | GO:0097136; Bcl-2 family protein complex | 2.213E-05 | 6.773E-03 | BCL2L1, MCL1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 7.071E-07 | 3.147E-05 | LDHB, CYP2A6, LDHA, GAA, ALOX15, ALDH1A1, AKR1B1, ALOX12, CYP2C19, HSD17B10 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 5.974E-07 | 3.147E-05 | LMNA, BCL2, TP53, BCL2L1, MCL1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04630 | Jak-STAT signaling pathway | 3.522E-05 | 7.837E-04 | THPO, BCL2, BCL2L1, MCL1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05014 | Amyotrophic lateral sclerosis (ALS) | 3.044E-05 | 7.837E-04 | BCL2, TP53, BCL2L1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 5.481E-05 | 9.757E-04 | ALOX15, ALOX12, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 6.916E-05 | 1.026E-03 | LDHA, TP53, HIF1A |
09160 Human Diseases | 09161 Cancers | hsa05222 | Small cell lung cancer | 1.455E-04 | 1.850E-03 | BCL2, TP53, BCL2L1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 2.482E-04 | 2.761E-03 | LDHA, BCL2, HIF1A |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 3.176E-04 | 3.140E-03 | ALOX15, ALOX12, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 3.702E-04 | 3.294E-03 | TP53, ESR1, HIF1A |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04151 | PI3K-Akt signaling pathway | 6.736E-04 | 4.226E-03 | BCL2, TP53, BCL2L1, MCL1 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 1.186E-03 | 6.210E-03 | BCL2, HIF1A, TP53, BCL2L1 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 1.782E-03 | 8.347E-03 | TP53, HIF1A, ESR1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 5.493E-04 | 4.226E-03 | ALOX15, CYP2C19 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00640 | Propanoate metabolism | 6.696E-04 | 4.226E-03 | LDHB, LDHA |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 5.881E-04 | 4.226E-03 | GAA, AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00620 | Pyruvate metabolism | 1.047E-03 | 5.823E-03 | LDHB, LDHA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00270 | Cysteine and methionine metabolism | 1.324E-03 | 6.546E-03 | LDHB, LDHA |
09120 Genetic Information Processing | 09124 Replication and repair | hsa03410 | Base excision repair | 7.123E-04 | 4.226E-03 | POLB, MPG |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
NA: NA | Lymphoid malignancies | NA | BCL2L1; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | BCL2; |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
C00-D49: Neoplasms | Leukemia | C90-C95 | BCL2; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | BCL2L1; TP53; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Gout | M10 | AKR1B1; |
C00-D49: Neoplasms | Prostate cancer | C61 | BCL2; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
C00-D49: Neoplasms | Relapsed or refractory chronic lymphocytic leukemia | NA | BCL2L1; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | AKR1B1; |
C00-D49: Neoplasms | Advanced melanoma | C43 | BCL2; |
C00-D49: Neoplasms | Advanced small cell lung cancer | NA | BCL2L1; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | AKR1B1; |
C00-D49: Neoplasms | Chronic lymphocytic leukaemia | C91 | BCL2; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic cataract | E10.36, E11.36 | AKR1B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | AKR1B1; |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR; |
C00-D49: Neoplasms | Breast cancer | C50 | BCL2; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR; |
C00-D49: Neoplasms | Cancer | C00-C96 | BCL2L1; TP53; BCL2; |
G00-G99: Diseases of the nervous system G00-G99 | Amyotrophic lateral sclerosis | G12.2 | BCL2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic neuropathy | E11.40 | AKR1B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic complication | E08-E13 | AKR1B1; |
C00-D49: Neoplasms | Multiple myeloma | C90 | BCL2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | BCL2; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | AKR1B1; TP53; |